FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890592362> ?p ?o ?g. }

• W2890592362 endingPage "e13457" @default.
• W2890592362 startingPage "e13457" @default.
• W2890592362 abstract "Sera anti-enteric neuronal antibodies (AENA), neuronal inflammation, and degeneration in myenteric plexus in patients with irritable bowel syndrome (IBS) were reported. Effects of sera AENA in patients with IBS are unclear.Patients with IBS met Rome III criteria were enrolled. Controls included healthy subjects (HS) and patients with slow transit functional constipation, inflammatory bowel disease, chronic intestinal pseudo-obstruction, and autoimmune diseases. Indirect immunofluorescence was used to detect AENA. Anti-enteric neuronal antibodies intensities were termed as 1 = weak fluorescence (mild positive); 2 = moderate fluorescence (moderate positive); 3 = very high fluorescence (intensive positive). Intensities of ≥1 were defined as positive and ≥2 were defined as obvious positive. Cultured myenteric neurons of small intestine from guinea pigs and human SH-Sy5Y cells were incubated with fetal bovine serum (FBS), HS sera, or IBS sera with or without AENA. Indirect immunofluorescence with anti-PGP9.5/DAPI/anti-active caspase-3 or TUNEL, Western blot, and flow cytometry were used to detect apoptosis.Overall, 293 patients with IBS were enrolled (41.7 ± 11.5 years). AENA-positive and obvious positive rates in IBS were higher than HS (76.8% vs 33%; 43.7% vs 7%; all P < 0.001). Myenteric neurons incubated with AENA moderate or intensive positive IBS sera showed higher rates of anti-active caspase-3 and TUNEL-positive cells than HS or FBS (20% ± 7.3% and 35% ± 13.3% vs 4.3% ± 1.5% and 0.9% ± 0.4%, respectively; 6.2% ± 2.0% and 10.2% ± 4.6% vs 1.3% ± 1.9% and 0.5%±0.5%, respectively; all P < 0.05). Human SH-Sy5Y cells incubated with AENA moderate or intensive positive IBS sera showed increased cleaved caspase-3 and Bax expression and decreased Bcl-2 expression. Flow cytometry showed apoptosis rates of these two groups were higher than that of AENA mild positive, negative, HS, and FBS (7.6%±0.8% and 10.7%±1.3% vs 5.0%±0.8%, 3.8%±0.3%, 3.4%±0.2% and, 2.8%±0.2%, P < 0.05).The AENA obvious positive rate in patients with IBS was higher than HS, and sera with higher levels of AENA promoted neuronal apoptosis. AENA-mediated neuropathy might exist in a subset of patients with IBS." @default.
• W2890592362 created "2018-09-27" @default.
• W2890592362 creator A5009689655 @default.
• W2890592362 creator A5024445302 @default.
• W2890592362 creator A5027616349 @default.
• W2890592362 creator A5028787257 @default.
• W2890592362 creator A5036541389 @default.
• W2890592362 creator A5038447655 @default.
• W2890592362 creator A5050635244 @default.
• W2890592362 creator A5053447232 @default.
• W2890592362 creator A5058283264 @default.
• W2890592362 creator A5086861827 @default.
• W2890592362 date "2018-09-17" @default.
• W2890592362 modified "2023-10-16" @default.
• W2890592362 title "Sera with anti-enteric neuronal antibodies from patients with irritable bowel syndrome promote apoptosis in myenteric neurons of guinea pigs and human SH-Sy5Y cells" @default.
• W2890592362 cites W1182588605 @default.
• W2890592362 cites W1885514854 @default.
• W2890592362 cites W1930520388 @default.
• W2890592362 cites W1971642669 @default.
• W2890592362 cites W1972949213 @default.
• W2890592362 cites W1976118863 @default.
• W2890592362 cites W1977928110 @default.
• W2890592362 cites W1981667918 @default.
• W2890592362 cites W1984595840 @default.
• W2890592362 cites W1990116068 @default.
• W2890592362 cites W1996180957 @default.
• W2890592362 cites W2010664054 @default.
• W2890592362 cites W2014618924 @default.
• W2890592362 cites W2015249757 @default.
• W2890592362 cites W2019559265 @default.
• W2890592362 cites W2022803736 @default.
• W2890592362 cites W2028184380 @default.
• W2890592362 cites W2028889492 @default.
• W2890592362 cites W2030324175 @default.
• W2890592362 cites W2030795964 @default.
• W2890592362 cites W2052880660 @default.
• W2890592362 cites W2067366187 @default.
• W2890592362 cites W2067489039 @default.
• W2890592362 cites W2070439977 @default.
• W2890592362 cites W2074983937 @default.
• W2890592362 cites W2079105897 @default.
• W2890592362 cites W2094066735 @default.
• W2890592362 cites W2099568050 @default.
• W2890592362 cites W2100304802 @default.
• W2890592362 cites W2104669609 @default.
• W2890592362 cites W2114613490 @default.
• W2890592362 cites W2121808013 @default.
• W2890592362 cites W2124594017 @default.
• W2890592362 cites W2124821571 @default.
• W2890592362 cites W2141786751 @default.
• W2890592362 cites W2143851985 @default.
• W2890592362 cites W2154958785 @default.
• W2890592362 cites W2159860161 @default.
• W2890592362 cites W2164303950 @default.
• W2890592362 cites W2194057378 @default.
• W2890592362 cites W2409417630 @default.
• W2890592362 cites W2557727373 @default.
• W2890592362 cites W2619527794 @default.
• W2890592362 cites W2751288039 @default.
• W2890592362 doi "https://doi.org/10.1111/nmo.13457" @default.
• W2890592362 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30230140" @default.
• W2890592362 hasPublicationYear "2018" @default.
• W2890592362 type Work @default.
• W2890592362 sameAs 2890592362 @default.
• W2890592362 citedByCount "5" @default.
• W2890592362 countsByYear W28905923622020 @default.
• W2890592362 countsByYear W28905923622021 @default.
• W2890592362 countsByYear W28905923622022 @default.
• W2890592362 countsByYear W28905923622023 @default.
• W2890592362 crossrefType "journal-article" @default.
• W2890592362 hasAuthorship W2890592362A5009689655 @default.
• W2890592362 hasAuthorship W2890592362A5024445302 @default.
• W2890592362 hasAuthorship W2890592362A5027616349 @default.
• W2890592362 hasAuthorship W2890592362A5028787257 @default.
• W2890592362 hasAuthorship W2890592362A5036541389 @default.
• W2890592362 hasAuthorship W2890592362A5038447655 @default.
• W2890592362 hasAuthorship W2890592362A5050635244 @default.
• W2890592362 hasAuthorship W2890592362A5053447232 @default.
• W2890592362 hasAuthorship W2890592362A5058283264 @default.
• W2890592362 hasAuthorship W2890592362A5086861827 @default.
• W2890592362 hasBestOaLocation W28905923621 @default.
• W2890592362 hasConcept C126322002 @default.
• W2890592362 hasConcept C142724271 @default.
• W2890592362 hasConcept C159654299 @default.
• W2890592362 hasConcept C190283241 @default.
• W2890592362 hasConcept C196795494 @default.
• W2890592362 hasConcept C203014093 @default.
• W2890592362 hasConcept C204232928 @default.
• W2890592362 hasConcept C2776907353 @default.
• W2890592362 hasConcept C2778236600 @default.
• W2890592362 hasConcept C2778271842 @default.
• W2890592362 hasConcept C2781112942 @default.
• W2890592362 hasConcept C553184892 @default.
• W2890592362 hasConcept C55493867 @default.
• W2890592362 hasConcept C71924100 @default.
• W2890592362 hasConcept C86803240 @default.
• W2890592362 hasConcept C90924648 @default.
• W2890592362 hasConceptScore W2890592362C126322002 @default.

• next